1. bookVolume 26 (2019): Issue 4 (December 2019)
Journal Details
First Published
01 May 2012
Publication timeframe
4 times per year
access type Open Access

Short-Term Consumption of Probiotic Yogurt Improved HDL-C of Type 2 Diabetes Mellitus Patients: A Double-Blind Randomized Controlled Trial

Published Online: 17 Feb 2020
Page range: 381 - 392
Received: 09 Nov 2019
Accepted: 14 Dec 2019
Journal Details
First Published
01 May 2012
Publication timeframe
4 times per year

Background and aims: Cardiovascular disease is the main complication and cause of morbidity and mortality in type 2 diabetes mellitus (T2DM) patients. The main cause of complication in T2DM is oxidative stress caused by insulin resistance, hence it can increase lipid profiles (cholesterol, LDL, and triglycerides) which exacerbates endothelial dysfunction. Among various functional foods with antioxidant effects, probiotic foods have been reported to suppress oxidative stress, and also improve the fasting blood glucose (FBG) and lipid profile in patients with T2DM. The aim of this clinical trial is to study the effects of probiotics and conventional yogurt on FBG and lipid profile in patients with T2DM.


1. Finkelstein EA, Chay J and Bajpai S. The economic burden of self-reported and undiagnosed cardiovascular diseases and diabetes on Indonesian households. PLoS ONE 9(6): e99572, 2014.Search in Google Scholar

2. Gregg EW, Li Y, Wang J et all. Changes in Diabetes-Related Complications in the United States, 1990–2010. New England Journal of Medicine 370:1514-1523, 2014.Search in Google Scholar

3. Murray RK, Granner DK, Mayes PA, Rodwell VW. Harper’s Biochemistry. 25th Edition, McGraw-Hill, Health Profession Division, New York.Search in Google Scholar

4. Linthout SV, Spillmann F, Schuitheiss HP, Tschope C. High-density lipoprotein at the interface of type 2 diabetes mellitus and cardiovascular disorders. Current pharmaceutical design 16(13): 1504-12, 2010.Search in Google Scholar

5. Chen AH, Tseng CH. The Role of Triglyceride in Cardiovascular Disease in Asian Patients with Type 2 Diabetes - A Systematic Review. The Riview of Diabetics Studies 10(2-3): 101–109, 2013.Search in Google Scholar

6. Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, Niafar M, Asghari-Jafarabadi M, Mofid V. Probiotic Yogurt Improves Antioxidant Status in Type 2 Diabetic Patients’. Nutrition, 28(5): 539–543, 2012.Search in Google Scholar

7. Pistrosch F, Natali A, Hanefeld M. Is Hyperglycemia a Cardiovascular Risk Factor?. Diabetes Care 34(Supplement 2): S128-131, 2011.Search in Google Scholar

8. Barter PJ. The Causes and Consequences of Low Levels of High Density Lipoproteins in Patients with Diabetes. Diabetes & Metabolism Journal, 35(2), 101–106, 2011.Search in Google Scholar

9. Kumar M, Nagpal R, Kumar R et all. Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases. Experimental Diabetes Research. Article ID 902917: 1–14, 2012.Search in Google Scholar

10. Rezaei M, Sanagoo A, Jouybari L, Behnampoo N, Kavosi A. The Effect of Probiotic Yogurt on Blood Glucose and cardiovascular Biomarkers in Patients with Type II Diabetes : A Randomized Controlled Trial. Evidence Based Care Journal 6(4): 25–35, 2017.Search in Google Scholar

11. Kawase M, Hashimoto H, Hosoda M, Morita H, Hosono A. Effect of administration of fermented milk containing whey protein concentrate to rats and healthy men on serum lipids and blood pressure. J Dairy Sci. 83(2): 255-63, 2000.Search in Google Scholar

12. Naruszewicz M, Johansson ML, Zapolska-Downar D, Bukowska H. Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. Am J Clin Nutr. 76(6): 1249-55, 2002.Search in Google Scholar

13. Dirienzo DB. Effect of Probiotics on Biomarkers of Cardiovascular Disease : Implications for Heart-Healthy Diets. Nutrition Reviews, 72(1): 18–29, 2013Search in Google Scholar

14. Yerlikaya O. Starter Cultures Used in Probiotic Dairy Product Preparation and Popular Probiotic Dairy Drinks. Food Science and Technology, 34(June): 221–229, 2014.Search in Google Scholar

15. Lemeshow S, Hosmer Jr DW, Klar J, Lwanga SK. Adequacy of Sample Size in Health Studies. 1st edn, World Health Organization. Chichester: John Wiley & Sons, 1990.Search in Google Scholar

16. Moreno-Indias I, Cardona F, Tinahones FJ, Queipo-Ortuno MI. Impact of the Gut Microbiota on the Development of Obesity and Type 2 Diabetes Mellitus. Frontiers in Microbiology 5(APR): 1–10, 2014.Search in Google Scholar

17. Han JL, Lin HL. Intestinal Microbiota and Type 2 Diabetes: From Mechanism Insights to Therapeutic Perspective. World Journal of Gastroenterology 20(47): 17737–17745, 2014.Search in Google Scholar

18. Yoo JY, Kim SS. Probiotics and Prebiotics: Present Status and Future. Nutrients 8(3): 1–20, 2016.Search in Google Scholar

19. Linares DM, Gómez C, Renes E et all. Lactic Acid Bacteria and Bifidobacteria with Potential to Design Natural Biofunctional Health-Promoting Dairy Foods. Frontiers in Microbiology 8(MAY): 1–11, 2017.Search in Google Scholar

20. Prasanna PHP, Grandison AS, Charalampopoulos D. Bifidobacteria in Milk Products: An Overview of Physiological and Biochemical Properties, Exopolysaccharide Production, Selection Criteria of Milk Products and Health Benefits. Food Research International 55: 247–262, 2014Search in Google Scholar

21. Tripathi MK, Giri SK. Probiotic Functional Foods: Survival of Probiotics during Processing and Storage. Journal of Functional Foods 9: 225–241, 2014.Search in Google Scholar

22. Rutella GS, Tagliazucchi D, Solieri L. Survival and Bioactivities of Selected Probiotic Lactobacilli in Yogurt Fermentation and Cold Storage: New Insights for Developing a Bifunctional Dairy Food. Food Microbiology 60: 54–61, 2016.Search in Google Scholar

23. Ataie-Jafari A, Larijani B, Majd HA, Tahbaz F. Cholesterol-lowering effect of probiotic yogurt in comparison with ordinary yogurt in mildly to moderately hypercholesterolemic subjects. Annals of Nutrition and Metabolism 54(1): 22-27, 2009.Search in Google Scholar

24. Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A et all. Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus. Journal of Dairy Science 94(7): 3288–3294, 2011.Search in Google Scholar

25. Zhang Q, Wu Y, Fei X. Effect of probiotics on glucose metabolism in patients with type 2 diabetes mellitus : A meta-analysis of randomized controlled trials. Medicina. 52(1), 28–34, 2016.Search in Google Scholar

26. Berger S, Raman G, Vishwanathan R, Jacques PF, Johnson EJ. Dietary cholesterol and cardiovascular disease: a systematic review and meta-analysis. The American journal of clinical nutrition 102(2): 276-294, 2015.Search in Google Scholar

27. Lecerf JM, De Lorgeril M. Dietary cholesterol: from physiology to cardiovascular risk. British Journal of Nutrition 106(1): 6-14, 2011.Search in Google Scholar

28. Sadrzadeh-Yeganeh H, Elmadfa I, Djazayery A, Jalali M, Heshmat R, Chamary M. The effects of probiotic and conventional yoghurt on lipid profile in women. British Journal of Nutrition 103(12): 1778-1783, 2010.Search in Google Scholar

29. Vesper H, Schmelz EM, Nikolova-Karakashian MN, Dillehay DL, Lynch DV, Merrill Jr AH. Sphingolipids in food and the emerging importance of sphingolipids to nutrition. J. Nutr. 129: 1239–1250, 1999.Search in Google Scholar

30. Mohammadshahi M, Veissi M, Haidari F, Javid AZ, Mohammadi F, Shirbeigi E. Effects of probiotic yogurt consumption on lipid profile in type 2 diabetic patients: A randomized controlled clinical trial. J Res Med Sci 19: 531-6, 2014.Search in Google Scholar

31. Miremadi F, Ayyash M, Sherkat F, Stojanovska L. Cholesterol reduction mechanisms and fatty acid composition of cellular membranes of probiotic Lactobacilli and Bifidobacteria. Journal of Functional Foods 9, 295-305, 2014.Search in Google Scholar

32. Micha R, Mozaffarian D. Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: A fresh look at the evidence. Lipids 45(10): 893–905, 2010.Search in Google Scholar

33. Burgos MAM, Torregrosa MDY, García MDM et all. Effects of a western-style diet high in cholesterol and saturated fat on the rabbit exocrine pancreas. Turkish Journal of Biology 39(5): 765–774, 2015.Search in Google Scholar

34. Ooi EMM, Watts GF, Ng TWK, Barrett PHR. Effect of dietary fatty acids on human lipoprotein metabolism: A comprehensive update. Nutrients 7(6): 4416–4425, 2015.Search in Google Scholar

35. Jansen S, Lôpez-Miranda J, Castro P et all. Low-fat and high-monounsaturated fatty acid diets decrease plasma cholesterol ester transfer protein concentrations in young, healthy, normolipemic men. American Journal of Clinical Nutrition, 72(1): 36–41, 2000.Search in Google Scholar

36. Poonuru S, Pathak SR, Vats HS, Pathak RD. Rapid reduction of severely elevated serum. Clinical Medicine and Research 9(1): 38–41, 2011.Search in Google Scholar

37. Hatefi Z, Soltani G, Khosravi S et all. Micro R-410 Binding Site Single Nucleotide Polymorphism rs13702 in Lipoprotein Lipase Gene is Effective to Increase Susceptibility to Type 2 Diabetes in Iranian Population. Adv Biomed Res 7:79, 2018.Search in Google Scholar

38. Karpe F, Dickmann JR, Frayn KN. Fatty acids, obesity, and insulin resistance: Time for a reevaluation. Diabetes, 60(10): 2441–2449, 2011.Search in Google Scholar

39. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoporteins in patients with NAFLD. J Clin Invest 115(5): 1343–1351, 2005.Search in Google Scholar

40. Aydin Ö, Nieuwdorp M, Gerdes V. The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes. Current Diabetes Reports 18(8): 55, 2018.Search in Google Scholar

41. Ohira H, Tsutsui W, Fujioka Y. Are Short Chain Fatty Acids in Gut Microbiota Defensive Players for Inflammation and Atherosclerosis?. Journal of Atherosclerosis and Thrombosis 24(7): 660–672, 2017.Search in Google Scholar

42. Schofield JD, Liu Y, Rao-Balakrishna P, Malik RA, Soran H. Diabetes Dyslipidemia. Diabetes Ther 7(2): 203–219, 2016.Search in Google Scholar

43. Tirosh A, Shai I, Bitzur R et all. Changes in triglyceride levels over time and risk of type 2 diabetes in young men. Diabetes Care, 31(10): 2032–2037, 2008.Search in Google Scholar

44. Barazzoni R, Deutz NEP, Biolo G et all. Carbohydrates and insulin resistance in clinical nutrition: Recommendations from the ESPEN expert group. Clinical Nutrition 36(2): 355–363, 2017.Search in Google Scholar

45. Parks EJ. Effect of Dietary Carbohydrate on Triglyceride Metabolism in Humans. The Journal of Nutrition 131(10): 2772S-2774S, 2001.Search in Google Scholar

46. Song Z, Xiaoli AM, Yang F. Regulation and Metabolic Significance of De Novo. Nutrients 10(10): 1383, 2018.Search in Google Scholar

47. Jung CH, Choi KM. Impact of high-carbohydrate diet on metabolic parameters in patients with type 2 diabetes. Nutrients 9(4): 1–21, 2107.Search in Google Scholar

48. Fujii H, Iwase M, Ohkuma T et all. Impact of dietary fiber intake on glycemic control, cardiovascular. American Journal of Clinical Nutrition 30(12): 159. 2013Search in Google Scholar

49. Papakonstantinou E, Triantafillidou D, Panagiotakos DB et all. A high-protein low-fat diet is more effective in improving blood pressure and triglycerides in calorie-restricted obese individuals with newly diagnosed type 2 diabetes. European Journal of Clinical Nutrition. Nature Publishing Group, 64(6): 595–602, 2010.Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo